2002
DOI: 10.1016/s0140-6736(02)08595-1
|View full text |Cite|
|
Sign up to set email alerts
|

Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

4
193
3
3

Year Published

2005
2005
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 303 publications
(203 citation statements)
references
References 27 publications
4
193
3
3
Order By: Relevance
“…It therefore becomes critical that decision makers are guided to allocate the available resources to the most cost effective strategies 14 . Studies conducted on cost effectiveness of HIV counseling and testing interventions have predominantly examined particular service provision models [15][16][17] . Further, these studies have used cost per HIV infection averted or cost per quality-adjusted life-year or disability adjusted life year saved as outcomes [15][16][17][18][19][20][21][22] .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…It therefore becomes critical that decision makers are guided to allocate the available resources to the most cost effective strategies 14 . Studies conducted on cost effectiveness of HIV counseling and testing interventions have predominantly examined particular service provision models [15][16][17] . Further, these studies have used cost per HIV infection averted or cost per quality-adjusted life-year or disability adjusted life year saved as outcomes [15][16][17][18][19][20][21][22] .…”
Section: Introductionmentioning
confidence: 99%
“…Studies conducted on cost effectiveness of HIV counseling and testing interventions have predominantly examined particular service provision models [15][16][17] . Further, these studies have used cost per HIV infection averted or cost per quality-adjusted life-year or disability adjusted life year saved as outcomes [15][16][17][18][19][20][21][22] . This article evaluates the cost effectiveness of facility-and home-based VCT models with the primary outcome measure of "extra cost per HIV sero-positive case identified."…”
Section: Introductionmentioning
confidence: 99%
“…The value of co-trimoxazole in reducing the morbidity and mortality associated with HIV infection has been well established through clinical trials conducted in industrialized 5,6 and developing countries. [7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] CTXp is associated with a 25-46% reduction in mortality among individuals infected with HIV in sub-Saharan Africa, even in areas with high bacterial resistance to the antibiotic. These improvements in survival have been accompanied by substantial reductions in severe disease events and in the number of hospital admissions linked to invasive bacterial disease, pneumonia, malaria and diarrhoea.…”
Section: Introductionmentioning
confidence: 99%
“…Effectiveness analyses have suggested that prevention would be the most "cost effective." 1,2 However, the continually rising rate of HIV infection worldwide, especially in sub-Saharan Africa, suggests that prevention programming to date has had limited effectiveness. 3 Inclusion of treatment as an integral component of HIV/AIDS health policy has recently been highlighted.…”
Section: Introductionmentioning
confidence: 99%